Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1Terminated 1Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Glioblastoma 5Keratosis, Actinic 4Brain Neoplasms 4Glioma 3Astrocytoma 3Skin Neoplasms 2Gliosarcoma 2Skull Base Neoplasms 1Precancerous Conditions 1Oligodendroglioma 1Neoplasms 1Leukoplakia, Oral 1Head and Neck Neoplasms 1Carcinoma, Basal Cell 1Breast Neoplasms 1

Interventions

Gemcitabine 34pembrolizumab 27Paclitaxel 21Cyclophosphamide 21Docetaxel 20Carboplatin 20Irinotecan 19Capecitabine 19Fluorouracil 17Bevacizumab 15Dexamethasone 14fludarabine 13Oxaliplatin 13Leucovorin 13Blood Specimen Collection 13Everolimus 12Cetuximab 12Ipilimumab 11Erlotinib Hydrochloride 11Rituximab 10Pemetrexed 10Cisplatin 10venetoclax 9Temozolomide 9Sunitinib 9Nivolumab 9Trastuzumab 8Interleukin-2 8aldesleukin 7Epoetin Alfa 7

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Neoplasms × Aminolevulinic Acid × Clear all
NCT05101798 2025-07-28

The Role of 5-Aminolevulinic Acid Fluorescence-Guided Surgery in Head and Neck Cancers: a Pilot Trial

Icahn School of Medicine at Mount Sinai

Phase 2 Terminated
7 enrolled 5 charts
Head & Neck

Head and Neck Neoplasms, Neoplasms, Skull Base Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡